Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising cases of blood cancer and related disorders
3.2.1.2 Innovations in leukapheresis devices and their procedures
3.2.1.3 Surge in R&D focus on cell-based therapies and immunotherapy
3.2.1.4 Supportive government initiatives and policies
3.2.2 Industry pitfalls & challenges
3.2.2.1 Expensive leukapheresis devices
3.2.2.2 Shortage of trained professionals
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.5.1 Core technologies
3.5.2 Adjacent technologies
3.6 Pricing analysis
3.7 Future market trends
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Disposables
5.3 Devices
5.3.1 Centrifugal devices
5.3.2 Membrane separators
5.3.3 Other devices
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Therapeutic
6.2.1 Hematology disorders
6.2.2 Autoimmune diseases
6.2.3 Other therapeutic applications
6.3 Research
6.3.1 Cancer research
6.3.2 Immunology research
6.3.3 Other research applications
Chapter 7 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Blood component providers and blood centers
7.3 Academic and research institutes
7.4 Pharmaceutical and biotechnology companies
7.5 Hospital and transfusion centers
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Asahi Kasei Corporation
9.2 Beijing ZKSK Technology Co., Ltd.
9.3 Baxter International Inc.
9.4 Cardinal Health, Inc.
9.5 Fresenius SE & Co. KGaA
9.6 Guangzhou DaJi Medical Science and Technology Co., Ltd.
9.7 Haemonetics Corporation
9.8 Macopharma
9.9 Medica SPA
9.10 Miltenyi Biotec
9.11 Mitra Industries Private Limited
9.12 Nikkiso Co. Ltd.
9.13 Puriblood Medical Co. Ltd.
9.14 SB-Kawasumi Laboratories, Inc.
9.15 Terumo BCT, Inc.
